Anna O Ermakova

7PUBLICATIONS
9CO-AUTHORS
Counselling psychologyPsychopharmacologyMolecular medicineToxicology (incl. clinical toxicology)Naturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 03, 2026
Psychological change processes in alcohol use disorder: A qualitative study of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy.

|Feb 27, 2026
A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) in patients with treatment-resistant depression.

Claire Roberts, Mathieu Seynaeve, Anna O Ermakova

|Dec 10, 2025
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial.

John Marsden, Michael Kelleher, Fiona Dunbar

|Apr 15, 2024
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants.

James Jonathan Rucker, Claire Roberts, Mathieu Seynaeve

|Oct 20, 2021
A narrative synthesis of research with 5-MeO-DMT.

Anna O Ermakova, Fiona Dunbar, James Rucker

|Sep 23, 2018
Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study.

Franziska Knolle, Anna O Ermakova, Azucena Justicia

Pageof 2

Frequent Collaborators

4 joint publications

James Rucker

2 joint publications

Franziska Knolle

2 joint publications

Claire Roberts

2 joint publications

John Marsden